Position in SNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,198,245,768
-$223,287,401 QoQ
Shares Held
28,088,274
-4.8% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#1
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dodge & Cox holds $7,907,700,561 across 13 Drug Manufacturers - General names. SNY ranks #3 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
23,677,567 | $2,991,423,814 | |
| 2 | GSK |
GSK plc
|
48,197,514 | $2,526,513,683 | |
| 3 | SNY |
Sanofi
This page
|
28,088,274 | $1,198,245,768 | |
| 4 | NVO |
Novo Nordisk A S
|
20,397,110 | $977,837,453 | |
| 5 | NVS |
Novartis AG
|
759,373 | $119,008,936 | |
| 6 | LLY |
ELI LILLY & Co
|
41,258 | $49,486,087 | |
| 7 | MRK |
Merck & Co., Inc.
|
135,750 | $17,443,875 | |
| 8 | AZN |
Astrazeneca PLC
|
55,949 | $10,609,049 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,198,245,768 | 28,088,274 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,421,533,169 | 29,504,632 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,737,631,347 | 56,492,599 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,253,578,458 | 68,931,747 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,464,711,797 | 71,718,315 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,059,286,941 | 73,193,057 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,627,888,959 | 75,220,588 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,397,006,656 | 76,297,183 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,741,359,393 | 77,109,633 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,796,904,597 | 78,125,609 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,891,382,097 | 78,250,193 | Shares | Sole | 2024-02-22 | |
| 2023-09-30 | $4,211,194,438 | 78,508,472 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,338,970,158 | 80,500,374 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,490,592,880 | 82,517,326 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,077,276,853 | 84,189,074 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,876,238,321 | 75,650,666 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,852,174,018 | 76,997,282 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,723,625,210 | 92,006,724 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,679,442,654 | 93,402,049 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,537,528,381 | 94,120,066 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,700,973,657 | 70,280,548 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,415,776,052 | 69,061,384 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,943,814,233 | 40,004,409 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,975,340,048 | 39,372,933 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,023,639,152 | 39,640,336 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,110,066,754 | 48,263,192 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||